Manulife (Manufacturers Life Insurance)
KYMR icon

Manulife (Manufacturers Life Insurance)’s Kymera Therapeutics KYMR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
119,503
-648
-0.5% -$55.7K 0.01% 762
2026
Q1 		$10M Sell
120,151
-15,743
-12% -$1.25M 0.01% 848
2025
Q4 		$10.6M Buy
135,894
+9,404
+7% +$635K 0.01% 843
2025
Q3 		$7.16M Sell
126,490
-25,675
-17% -$1.16M 0.01% 1029
2025
Q2 		$6.64M Buy
152,165
+9,578
+7% +$330K 0.01% 1036
2025
Q1 		$3.9M Sell
142,587
-4,709
-3% -$172K ﹤0.01% 1267
2024
Q4 		$5.93M Buy
147,296
+19,029
+15% +$859K 0.01% 1127
2024
Q3 		$6.07M Sell
128,267
-1,810
-1% -$79.9K 0.01% 1125
2024
Q2 		$3.88M Buy
130,077
+15,320
+13% +$530K ﹤0.01% 1273
2024
Q1 		$4.61M Buy
114,757
+14,684
+15% +$525K ﹤0.01% 1226
2023
Q4 		$2.55M Buy
100,073
+23,093
+30% +$413K ﹤0.01% 1396
2023
Q3 		$1.07M Sell
76,980
-4,410
-5% -$88.7K ﹤0.01% 1695
2023
Q2 		$1.87M Buy
81,390
+5,449
+7% +$156K ﹤0.01% 1431
2023
Q1 		$2.25M Buy
75,941
+10,955
+17% +$353K ﹤0.01% 1370
2022
Q4 		$1.66M Sell
64,986
-123
-0.2% -$3.28K ﹤0.01% 1435
2022
Q3 		$1.43M Sell
65,109
-716
-1% -$18.9K ﹤0.01% 1474
2022
Q2 		$1.33M Buy
65,825
+4,412
+7% +$103K ﹤0.01% 1527
2022
Q1 		$2.56M Buy
61,413
+43,674
+246% +$1.84M ﹤0.01% 1444
2021
Q4 		$1.12M Buy
17,739
+423
+2% +$24.6K ﹤0.01% 1761
2021
Q3 		$1.02M Buy
17,316
+1,151
+7% +$66.7K ﹤0.01% 1822
2021
Q2 		$784K Buy
16,165
+10,051
+164% +$436K ﹤0.01% 2132
2021
Q1 		$238K Buy
6,114
+49
+0.8% +$2.95K ﹤0.01% 2772
2020
Q4 		$376K Buy
+6,065
New +$296K ﹤0.01% 2382

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KYMR Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Kymera Therapeutics (KYMR) stake by 0.54% in Q2 2026, selling an estimated $55.7K and leaving 119,503 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #762.

Manulife (Manufacturers Life Insurance) first reported a position in KYMR in Q4 2020 and has held it in 23 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 119,503 shares of Kymera Therapeutics worth $13.7M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 648 Kymera Therapeutics shares in Q2 2026, an estimated $55.7K.
  • Kymera Therapeutics made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #762 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.